Eidelman Virant Capital’s Evogene EVGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $96K | Hold |
11,700
| – | – | 0.07% | 153 |
|
|
2022
Q2 | $101K | Hold |
11,700
| – | – | 0.07% | 158 |
|
|
2022
Q1 | $152K | Buy |
11,700
+400
| +4% | +$5.2K | 0.08% | 157 |
|
|
2021
Q4 | $185K | Buy |
+11,300
| New | +$185K | 0.07% | 179 |
|
|
2021
Q1 | – | Sell |
-1,510
| Closed | -$71K | – | 178 |
|
|
2020
Q4 | $71K | Sell |
1,510
-3,850
| -72% | -$181K | 0.03% | 163 |
|
|
2020
Q3 | $219K | Sell |
5,360
-1,100
| -17% | -$44.9K | 0.12% | 118 |
|
|
2020
Q2 | $65K | Buy |
+6,460
| New | +$65K | 0.05% | 109 |
|
|
2019
Q3 | – | Sell |
-6,360
| Closed | -$102K | – | 119 |
|
|
2019
Q2 | $102K | Buy |
+6,360
| New | +$102K | 0.05% | 111 |
|
|
2017
Q3 | – | Sell |
-3,230
| Closed | -$163K | – | 109 |
|
|
2017
Q2 | $163K | Hold |
3,230
| – | – | 0.09% | 94 |
|
|
2017
Q1 | $172K | Sell |
3,230
-1,540
| -32% | -$82K | 0.12% | 86 |
|
|
2016
Q4 | $243K | Buy |
4,770
+2,840
| +147% | +$145K | 0.14% | 87 |
|
|
2016
Q3 | $123K | Sell |
1,930
-230
| -11% | -$14.7K | 0.08% | 105 |
|
|
2016
Q2 | $135K | Buy |
2,160
+50
| +2% | +$3.13K | 0.08% | 111 |
|
|
2016
Q1 | $138K | Buy |
2,110
+380
| +22% | +$24.9K | 0.09% | 110 |
|
|
2015
Q4 | $139K | Buy |
+1,730
| New | +$139K | 0.08% | 130 |
|